AGM Statement

Agenda 1 : Approval of Proposed FY 2021 Financial Statements

- Dividend per share : Common Stock 850 KRW, Preferred Stock 900 KRW

Agenda 2 : Approval of Amendment of Article of Incorporation

-

-

-

-

In order to sell medical devices, 'medical device manufacturing and sales business' is

to be added in accordance with the Medical Device Act

Addition of 'licensing business of intellectual property rights such as patents' to continue

the intellectual property rights licensing business such as mobile patents, which has been

carried out incidentally by the MC business

Addition of 'development and sales of blockchain-based software, and trading and

brokerage of cryptographic assets' to provide blockchain platform services

'Production and sales of functional materials such as glass powder' is to be added to manufacture/sell functional glass materials (enamel and antibacterial functional glass

powder)

Agenda 3 : Appointment of Directors

- Agenda 3-1 : Outside Director Sang-Goo Lee (Re-appointment)- Agenda 3-2 : Outside Director Choong-Yuel Yoo (New appointment)

Agenda 4 : Appointment of Audit Committee Member

- Agenda 4-1 : Audit Committee Member Sang-Goo Lee (New appointment)- Agenda 4-2 : Audit Committee Member Choong-Yuel Yoo (New appointment)

Agenda 5 : Approval of Compensation Limit for Directors

- Compensation Limit 9.0 Billion KRW (Previous Year : 9.0 Billion KRW)